Developments TIAP and Evotec expand LAB150 BRIDGE partnership to Include Amgen Toronto Innovation Acceleration Partners (TIAP) and Evotec (NASDAQ:EVO; FSE: EVT) have expanded LAB150, their translational BRIDGE partnership, to include Amgen (NASDAQ:AMGN) as a strategic partner. The expansion... October 17, 2022